Pegylated Liposomal Doxorubicin in combination with Ecteinescidin 743

Details for Australian Patent Application No. 2005298364 (hide)

Owner Pharma Mar S.A., Sociedad Unipersonal. Ortho Biotech Products L.P.

Inventors Gilles, Erard; Trifan, Ovid; Teitelbaum, April; Sternas, Lars-Axel; Van De Velde, Helgi

Agent Davies Collison Cave

Pub. Number AU-B-2005298364

PCT Pub. Number WO2006/046080

Priority 60/622,163 26.10.04 US

Filing date 26 October 2005

Wipo publication date 4 May 2006

Acceptance publication date 26 March 2009

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/046080 Priority application(s): WO2006/046080

26 July 2007 Change of Name(s) of Applicant(s), Section 104

  Ortho Biotech Products L.P.; Pharma Mar S.A. The name of the applicant has been changed to Pharma Mar S.A., Sociedad Unipersonal.; Ortho Biotech Products L.P.

26 March 2009 Application Accepted

  Published as AU-B-2005298364

23 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005298369-Water-softening product, its preparation and its use

2005298360-Applications of isolated nucleic acid fragments comprising CpG islands